I
ISSUER//CIK 0001520047
Immunoclin Corp
Exchange
—
Entity type
operating
Fiscal year end
Jan 31
Headquarters
NV
Recent Filings
- SC 13D92.1 KBImmunoclin CorpApr 20, 2:44 PM ET·0001571049-16-014044
- SC 13D108.0 KBImmunoclin CorpApr 14, 4:38 PM ET·0001571049-16-013912
- 8-K14.2 KBImmunoclin CorpApr 11, 12:59 PM ET·0001144204-16-093633
- 8-K92.1 KBImmunoclin CorpApr 4, 4:41 PM ET·0001144204-16-092599
- 46.1 KBImmunoclin CorpApr 1, 3:03 PM ET·0001468429-16-000023
- 34.3 KBImmunoclin CorpApr 1, 3:01 PM ET·0001468429-16-000022
- SC 13D140.8 KBImmunoclin CorpMar 29, 3:53 PM ET·0001144204-16-090915
- SC 13D37.5 KBImmunoclin CorpMar 29, 3:06 PM ET·0001144204-16-090886
- SC 13D58.7 KBImmunoclin CorpMar 29, 1:43 PM ET·0001144204-16-090857
- SC 13D62.4 KBImmunoclin CorpMar 29, 1:32 PM ET·0001144204-16-090848
Insiders
2Tickers
No tickers on record
Addresses
business
1420 N STREET NW, SUITE 102
WASHINGTON, DC, X1, 20005
mailing
1420 N STREET NW, SUITE 102
WASHINGTON, DC, X1, 20005
Former Names
- PHARMA INVESTING NEWS, INC.2014-01-21